N06.22
Secondary membranous nephropathy with isolated proteinuria
Clinical Classification Guidelines
Use Additional Code
- code, if applicable, for adverse effect of drug causing membranous nephropathy
Inclusion Terms
- Secondary membranous nephropathy, NOS
Excludes Type 1
- secondary membranous nephropathy with nephrotic syndrome (N04.22)
Code First
- , if applicable, other disease or disorder or poisoning causing membranous nephropathy
Medical Intelligence & Overview
Secondary membranous nephropathy with isolated proteinuria is a kidney disorder characterized by damage to the glomeruli, which are tiny structures in the kidneys responsible for filtering blood. In this condition, immune responses lead to the thickening of the glomerular basement membrane, resulting in protein leaking into the urine (proteinuria). The term ‘secondary’ indicates that this condition arises due to other underlying factors or diseases, distinguishing it from primary membranous nephropathy which occurs without an identifiable cause. Isolated proteinuria refers to the presence of excess protein in the urine without accompanying blood or other abnormalities. Understanding this condition can help in proper diagnosis, management, and treatment planning.
Causes & Symptoms
Clinical Causes: Use of certain medications such as NSAIDs or penicillamine Underlying autoimmune diseases like lupus erythematosus Chronic infections, including hepatitis B or C Malignancies or cancers that trigger immune responses Other systemic conditions affecting kidney function Exposure to certain toxins or environmental factors
Key Symptoms: Persistent proteinuria detected incidentally or during routine tests Swelling or edema, especially in the legs, ankles, or around the eyes Foamy urine due to high protein content Unexplained weight gain related to fluid retention Fatigue or weakness which may result from kidney function impairment Hypertension or increased blood pressure in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of laboratory tests and clinical assessments. A urine analysis reveals elevated levels of protein, confirming proteinuria. Blood tests may evaluate kidney function and identify potential underlying causes, such as autoimmune markers or infection indicators. Kidney biopsy remains a crucial tool to confirm the diagnosis, assess the extent of glomerular damage, and differentiate between primary and secondary forms of membranous nephropathy. Imaging studies are typically not primary but can assist in ruling out alternative diagnoses.
Treatment Protocols: Use of medications such as ACE inhibitors or angiotensin receptor blockers to reduce proteinuria and protect kidney function Immunosuppressive therapies if autoimmune processes are involved Treating underlying infections with appropriate antiviral or antimicrobial agents Managing blood pressure through lifestyle modifications and medications Dietary modifications, including reducing salt intake and controlling protein consumption Monitoring kidney function regularly to track disease progression
Clinical Advice & FAQs
Billing Guidance
Is N06.22 a billable ICD-10 code?
Yes, N06.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N06.22?
Clinical documentation must specify the nature of Secondary membranous nephropathy with isolated proteinuria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference